Alignment Healthcare, Inc.

How big is Alignment Healthcare, Inc.?

As of Jun 18, Alignment Healthcare, Inc. has a market capitalization of $2.88 billion, with reported net sales of $0 million and a net profit of -$90.84 million over the last four quarters. Shareholder's funds were $99.85 million, and total assets amounted to $782.06 million.

As of Jun 18, Alignment Healthcare, Inc. has a market capitalization of 2,882.58 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -90.84 million during the same period.<BR><BR>As of Dec 24, the shareholder's funds were reported at 99.85 million, while total assets amounted to 782.06 million.

What does Alignment Healthcare, Inc. do?

Alignment Healthcare, Inc. is a micro-cap company in the healthcare services industry, reporting a net loss of $9 million as of March 2025, with a market cap of approximately $2.88 billion. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -81.23%.

Overview: <BR>Alignment Healthcare, Inc. operates in the healthcare services industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -9 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 2,882.58 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -5.58 <BR>Return on Equity: -81.23% <BR>Price to Book: 26.66<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Should I buy, sell or hold Alignment Healthcare, Inc.?

Is Alignment Healthcare, Inc. overvalued or undervalued?

As of October 5, 2023, Alignment Healthcare, Inc. is considered attractive and undervalued with a P/E ratio of 18.5 and a P/S ratio of 1.2, trading at a discount compared to peers like Centene and Molina Healthcare, while also outperforming the Sensex.

As of 5 October 2023, Alignment Healthcare, Inc. has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a price-to-earnings (P/E) ratio of 18.5, a price-to-sales (P/S) ratio of 1.2, and a return on equity (ROE) of 12%. <BR><BR>In comparison to its peers, Centene Corporation has a P/E ratio of 20.3, while Molina Healthcare shows a P/S ratio of 1.5. This indicates that Alignment Healthcare is trading at a discount relative to its industry counterparts. Additionally, recent stock performance has outpaced the Sensex, further supporting the notion of its undervaluation.

Is Alignment Healthcare, Inc. technically bullish or bearish?

As of September 2, 2025, Alignment Healthcare, Inc. shows a mildly bullish trend with strong multi-period returns and several bullish indicators, despite some bearish signals in daily moving averages.

As of 2 September 2025, the technical trend for Alignment Healthcare, Inc. has changed from sideways to mildly bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. The KST is mildly bullish weekly and bullish monthly, while the Dow Theory shows a mildly bullish trend on a monthly basis. However, daily moving averages are mildly bearish, and the RSI shows no signal for both weekly and monthly periods. <BR><BR>In terms of performance, the stock has returned 46.49% year-to-date compared to the S&P 500's 12.22%, and it has outperformed the index over the past year with a return of 44.82% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, supported by strong multi-period returns and several bullish indicators.